Recent Updates
Recently added Catalysts
INO Positive Sentiment Score: 75/100

INOVIO to Participate in Upcoming Scientific Conferences

Friday, May 8, 2026 2 min read
Key Takeaway: INOVIO (NASDAQ:INO) has announced its participation in two prominent scientific conferences, the American Society of Gene and Cell Therapy Annual Meeting in Boston and the American Society of Clinical Oncology Annual Meeting in Chicago. At these events, the company will present research related to gene treatments for hemophilia A and DNA immunotherapy for Recurrent Respiratory Papillomatosis. Following the presentations, abstracts will be made available on INOVIO's website to share further details of the research.

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is advancing its presence in the scientific community by participating in significant conferences.
  • The company is showcasing innovative research in gene therapy and immunotherapy.
  • Presentations at major industry meetings can enhance INOVIO's visibility and credibility.
  • Available abstracts post-presentation will provide additional insights into their research.

Full Press Release Details

PLYMOUTH MEETING, Pa., May 8, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conferences:
American Society of Gene and Cell Therapy Annual Meeting (Boston)
Poster Presentation: Bleeding phenotype correction in hemophilia A mice following in vivo Factor VIII gene transfer by electroporation in skeletal muscle cells
Date: Tuesday, May 12
Time: 5 - 6:30 PM ET
American Society of Clinical Oncology Annual Meeting (Chicago)
Poster Presentation: B cell responses in Recurrent Respiratory Papillomatosis patients treated with DNA immunotherapy INO-3107
Date: Saturday, May 30
Time: 1:30 - 4:30 PM CDT
Available abstracts will be shared on INOVIO's website following presentations.
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

What is INOVIO's focus in biotechnology?

INOVIO specializes in developing DNA medicines for HPV-related diseases, cancer, and infections.

When is INOVIO presenting at the American Society of Gene and Cell Therapy?

INOVIO will present on May 12, from 5 - 6:30 PM ET in Boston.

What topic will be discussed at the ASCO Annual Meeting?

The presentation will cover B cell responses in Recurrent Respiratory Papillomatosis patients treated with INO-3107.

Where can I find INOVIO's presentation abstracts?

Abstracts will be available on INOVIO's website after the presentations.

How can I contact INOVIO's media relations?

You can contact media relations through Jennie Willson at (267) 429-8567.

Tags: INO Viatris Investor Conferences Healthcare INOVIO DNA medicines scientific conferences hemophilia A immunotherapy
Last updated: May 8, 2026